Non-peptide

LGD-3303

Also known as

LGD3303 · LGD 3303

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Experimental SARM	A nonsteroidal androgen-receptor compound discussed for strength and muscle. Rat findings do not establish human effectiveness or safety.
Different from LGD-4033	LGD-3303 is not LGD-4033 or Ligandrol. Generic LGD names and seller labels do not verify which compound or amount a report concerns.

Notes

LGD-3303 is an experimental SARM discussed for strength, muscle gain and a harder-looking physique. It is a different compound from LGD-4033, also called Ligandrol. Favorable reports sit alongside no early response, hair shedding and hormonal suppression; human effectiveness and safety are not established.

An androgen-receptor compound. SARMs interact with the same cellular receptor as testosterone. LGD-3303 is a non-peptide, nonsteroidal research compound; rat muscle findings explain interest in it but do not establish a human muscle-building treatment. Vajda et al. — LGD-3303 pharmacokinetics and pharmacodynamics (Animal context · Accessed 2026-09-30)

Forms and names matter. The discussion involves capsules, tablets and liquid products sold as research chemicals. “LGD” alone does not identify 3303, and seller-labelled milligrams do not verify the contents. Oral amounts cannot be transferred to an injectable preparation. Where to find LGD 3303 (Personal report · Accessed 2026-09-30)

Source context — Vajda et al. — LGD-3303 pharmacokinetics and pharmacodynamics: Primary animal study, Ligand Pharmaceuticals authors. No human benefit, safety or kinetics established. ResearchGate metadata says December 2008; journal issue 2009.

Source context — Where to find LGD 3303: Unverified tablets and anonymous report; compound unresolved. Future plans are not observed exposure. Sourcing content omitted.

What people notice

Strength and muscle fullness	Some report stronger lifts and fuller muscles. A nine-week account also used Dbol and credited muscle memory after returning to training.
Harder-looking physique	A TRT user preferred 3303 to 4033 for hardness, veins and abdominal definition. That appearance does not establish fat loss or lower risk.
No early gains; uncomfortable pumps	One 16 mg/day user noticed no gain after a week. Other accounts describe pronounced, uncomfortable pumps or fatigue despite maintained strength.

Notes

Strength and fuller-looking muscle. A nine-week user reported regained strength and about 15 lb of muscle while also taking methandienone, called Dbol. They explicitly credited muscle memory after returning to training; this is not 15 lb attributable to LGD-3303. Anyone here run LGD 3033? What was your experience? (Personal report · Accessed 2026-09-30)

Performance during a cut. A commenter described fuller muscles around week one and better strength around week two while dieting. That report gives no usable 3303 amount and cannot establish muscle retention or fat loss. Rad 140 vs LGD 3303 Conversation (Community discussion · Accessed 2026-09-30)

Hardness and vascularity. One testosterone-replacement-therapy (TRT) user preferred 3303 to 4033 for firmness, visible veins and abdominal definition. Neither amount was given, and TRT prevents a clean comparison. LGD-3303 comparisons (Community discussion · Accessed 2026-09-30)

“Dry” describes appearance. Users contrast harder-looking muscle and more visible veins with the bloated or water-heavy look they associate with LGD-4033. This vocabulary does not prove fat loss, retained muscle or lower health risk. LGD-3303 comparisons (Community discussion · Accessed 2026-09-30) · Anyone here run LGD 3033? What was your experience? (Personal report · Accessed 2026-09-30)

Another account: 8 mg morning and 8 mg night. That equals 16 mg/day; the contributor reported no gain after one week. Form and route were not specified in the comment. A larger daily total did not guarantee an early response. Rad 140 vs LGD 3303 Conversation (Community discussion · Accessed 2026-09-30)

Tiredness can coexist with maintained strength. The show-preparation logger reported fatigue while retaining or improving lifts, amid a low-carb diet, testosterone and other agents. They could not isolate its cause. My LGD 3303 Experiences (Personal report · Accessed 2026-09-30)

Pumps can be uncomfortable. One contributor described pronounced pumps alongside fast visible mass changes and suppression. That is their experience, not a signal that discomfort proves an effective or safe product. Anybody have experience with lgd 3303? (Community discussion · Accessed 2026-09-30)

Source context — Anyone here run LGD 3033? What was your experience?: Single retrospective account; methandienone, retraining/muscle memory and unverifiable identity prevent LGD-only attribution. Predicted solo lethargy was not observed.

Source context — Rad 140 vs LGD 3303 Conversation: Original post deleted despite indexed search text. Comments remain accessible. No lab documents, unknown formulations/routes, co-use. Unrelated 4033 liquid millilitres have no concentration and must not be converted.

Source context — LGD-3303 comparisons: Different people, unknown doses, unverified products, TRT in favorable account. No controlled head-to-head inference.

Source context — My LGD 3303 Experiences: Author signature identifies supplement representative. Testosterone and many agents confound; 12 mg/day was a plan, not confirmed. Public photos not inspected for outcomes.

Source context — Anybody have experience with lgd 3303?: Self-styled coach's assertion is advice/opinion, not measured kinetics or safety. Sponsorship not established. Several hidden replies were not opened.

Doses people talk about

5–20 mg/day oral charts	A circulated vendor/forum band. Separate stacked accounts describe 10 mg/day with Dbol or 10 mg twice daily with enclomiphene, totaling 20 mg/day.
8 mg morning plus 8 mg night	16 mg/day in a one-week account; its comment did not specify form or route.
4 mg, then 8 mg/day capsules	A bodybuilding log reports one 4 mg capsule, later two daily, with testosterone and other agents. Three capsules remained a plan.
5 mg/day identity gap	One tablet report reaches week four, but never resolves whether it was 4033 or 3303. The later 7.5 mg amount was only planned.

Notes

Circulated oral band: about 5–20 mg/day. This is a preserved vendor/forum template. Separate accounts report 10 mg/day with Dbol and 10 mg twice daily with enclomiphene, meaning 20 mg total per day. Neither stack establishes a useful or safe dose. Anyone here run LGD 3033? What was your experience? (Personal report · Accessed 2026-09-30) · Rad 140 vs LGD 3303 Conversation (Community discussion · Accessed 2026-09-30)

Capsule log: 4 mg, then 8 mg/day. The bodybuilding log began with one 4 mg capsule and later reported two daily. Three capsules were still a plan; testosterone and numerous other agents were also used. My LGD 3303 Experiences (Personal report · Accessed 2026-09-30)

The 5 mg/day report has an identity gap. A tablet user reported that total at week four, but a reply asks whether it was 4033 or 3303 without a visible answer. Their planned 7.5 mg in week five is not confirmed use. Where to find LGD 3303 (Personal report · Accessed 2026-09-30)

Source context — Where to find LGD 3303: Unverified tablets and anonymous report; compound unresolved. Future plans are not observed exposure. Sourcing content omitted.

Half-life, onset & duration

Felt onset	One logger reports first-day extra reps while acknowledging expectation. Separate users describe changes at 1–2 weeks.
Felt duration	No dependable one-dose benefit window. A stacked user's retained effects two months after stopping do not establish that the drug stayed active that long.
Half-life	No validated human value here. The circulated 5–6 or 6–7 hours is unsupported as human timing; the primary oral rat groups measured 4.3–8.7 hours.

Notes

First-day excitement versus no change at five days. One 10 mg/day logger described extra reps immediately and acknowledged it could be expectation. Another poster felt nothing after five days. These are separate users, not a dependable onset window. LGD 3303 — early log and nonresponse (Community discussion · Accessed 2026-09-30)

About one to two weeks in one account. The dieting commenter noticed veins/fullness around week one and strength around week two. Another user noticed no gains after a week at 16 mg/day. Early irritability is a side effect, not proof of muscle growth. Rad 140 vs LGD 3303 Conversation (Community discussion · Accessed 2026-09-30)

No dependable one-dose benefit window. Workout-timing arguments do not establish how many hours a dose feels effective. One commenter reported irritability 1–2 hours after dosing while sleep stayed unchanged; that does not measure beneficial duration. Rad 140 vs LGD 3303 Conversation (Community discussion · Accessed 2026-09-30) · Anybody have experience with lgd 3303? (Community discussion · Accessed 2026-09-30)

About two months after stopping in one stacked report. The Dbol user described lasting effects after the nine-week course. Regained muscle, training and the other drug make this a retention story, not evidence that LGD-3303 remains active for two months. Anyone here run LGD 3033? What was your experience? (Personal report · Accessed 2026-09-30)

5–6 hours and 6–7 hours are circulated claims. The bodybuilding repost draws on rat research; the Reddit debate repeats 6–7 hours without human measurements. These claims concern decline in drug concentration, not how long strength gains or a workout feeling lasts. LGD-3303 (Not Ligandrol) (Secondhand community claim · Accessed 2026-09-30) · Where to buy LGD-3303 — timing disagreement (Community discussion · Accessed 2026-09-30)

Divided use is disputed. Some contributors argue for two or three administrations daily; another favors once-daily use around training. Frequency preferences do not measure human half-life, and no validated human value emerges from these accounts. Where to buy LGD-3303 — timing disagreement (Community discussion · Accessed 2026-09-30) · Anybody have experience with lgd 3303? (Community discussion · Accessed 2026-09-30)

Rat half-life measurements stay separate. The 2009 paper's day-14 oral rat groups had mean elimination half-lives of 4.3–8.7 hours. Those are animal drug-concentration measurements, not a human interval, a felt-effect duration or an oral-to-injection conversion. Vajda et al. — LGD-3303 pharmacokinetics and pharmacodynamics (Animal context · Accessed 2026-09-30)

Source context — LGD 3303 — early log and nonresponse: Unverified products, supplement plans, missing final outcome. Sponsor-rich forum; duplicate #39/#40 are the same poster, not corroboration.

Source context — LGD-3303 (Not Ligandrol): Reposted research interpretation, not human use log. Site has commercial bodybuilding links. Rat-to-human dose/prostate/suppression extrapolations rejected.

Source context — Where to buy LGD-3303 — timing disagreement: Sourcing thread; names, prices and purchase directions excluded. Rat-paper-checking reply in original record not visible in this current extraction; not claimed freshly inspected.

Cycles people discuss

6–8-week charts	Template language differs from individual accounts: one describes six weeks with enclomiphene, another about nine weeks with Dbol.
Planned courses and recovery	Longer course plans, including twelve weeks, were not confirmed completions. No reliable off-period or hormonal-recovery timetable follows from these accounts.

Notes

Six to eight weeks is template language. The original chart records that range. A commenter actually described six weeks with enclomiphene; the Dbol account described about nine weeks. These distinct histories do not establish an ideal course. Rad 140 vs LGD 3303 Conversation (Community discussion · Accessed 2026-09-30) · Anyone here run LGD 3033? What was your experience? (Personal report · Accessed 2026-09-30)

Plans are different from completed courses. The ambiguous-LGD user was at week four and planned six more weeks. A bodybuilding logger proposed twelve weeks without a verified finish. No reliable off-period or hormonal-recovery timetable follows. Where to find LGD 3303 (Personal report · Accessed 2026-09-30) · LGD 3303 — early log and nonresponse (Community discussion · Accessed 2026-09-30)

Source context — Where to find LGD 3303: Unverified tablets and anonymous report; compound unresolved. Future plans are not observed exposure. Sourcing content omitted.

Stacks

Dbol	One nine-week report combines 10 mg/day LGD-3303 with 20 mg/day methandienone. Its strength and appearance changes cannot be assigned to 3303 alone.
TRT or enclomiphene	Both appear in separate favorable accounts. Their use does not establish interaction safety or prevent suppression.

Notes

grandmaster_zach, lines 43–55: 10 mg/day 3303 with 20 mg/day Dbol about nine weeks, regained strength/mass, dryness/veins, effects at two months off. Replies question liver burden. Anyone here run LGD 3033? What was your experience? (Personal report · Accessed 2026-09-30)

Suppression can accompany favorable gym results. A six-week user reported total testosterone about 60% below baseline immediately afterward despite enclomiphene. They later reported returning to baseline after post-cycle treatment. This is one undocumented account, not proof that treatment guarantees recovery. Rad 140 vs LGD 3303 Conversation (Community discussion · Accessed 2026-09-30)

Other drugs complicate both effects and risks. Dbol, TRT and enclomiphene appear in favorable stories. Interaction safety and long-term outcomes are unclear; lipid and hormone monitoring discussions do not establish that a stack is safe. Anyone here run LGD 3033? What was your experience? (Personal report · Accessed 2026-09-30) · LGD-3303 comparisons (Community discussion · Accessed 2026-09-30)

Source context — LGD-3303 comparisons: Different people, unknown doses, unverified products, TRT in favorable account. No controlled head-to-head inference.

Watch for

Hormonal suppression	A six-week user reports testosterone about 60% below baseline despite enclomiphene, then later recovery after post-cycle treatment. That single account does not guarantee recovery.
Hair, skin and mood	Shedding, oily skin, acne and irritability occur in reports, including shedding on 3303 but not 4033 for one person.
Serious class risks	The saved FDA warning identifies SARMs as unapproved drugs and lists liver injury, heart attack or stroke, sexual dysfunction and fertility or pregnancy harms. These are not 3303-specific rates.
Products and severe symptoms	Unverified oral research products do not establish injectable equivalents. Chest pain, sudden neurological changes or severe allergic symptoms need medical assessment.

Notes

Hair, skin and mood are real tradeoffs in reports. Accounts include shedding, oily skin, acne and irritability. One user had shedding on 3303 but none on 4033. A dry-looking physique does not make these effects predictable or harmless. Rad 140 vs LGD 3303 Conversation (Community discussion · Accessed 2026-09-30) · LGD-3303 comparisons (Community discussion · Accessed 2026-09-30)

FDA warning: serious class risks. SARMs are unapproved drugs and cannot legally be marketed in the U.S. as supplements or drugs. FDA lists liver injury, heart attack/stroke, sexual dysfunction, infertility and miscarriage among associated harms. These are class warnings, not measured 3303-specific rates. FDA warning about SARMs among teens and young adults (Official context · Accessed 2026-09-30)

Severe symptoms need medical care. Chest pain, sudden neurological changes, severe allergic symptoms or uncontrolled blood pressure/glucose need medical assessment. Feeling fine or finishing a forum calendar does not demonstrate recovery.

Source context — LGD-3303 comparisons: Different people, unknown doses, unverified products, TRT in favorable account. No controlled head-to-head inference.

Source context — FDA warning about SARMs among teens and young adults: Class-wide warning, not LGD-3303-specific rate or proof every listed harm occurs in each user. No page publication date verified.

Source context — Where to find LGD 3303: Unverified tablets and anonymous report; compound unresolved. Future plans are not observed exposure. Sourcing content omitted.

Full notes

What it is and why people compare it

An androgen-receptor compound. SARMs interact with the same cellular receptor as testosterone. LGD-3303 is a non-peptide, nonsteroidal research compound; rat muscle findings explain interest in it but do not establish a human muscle-building treatment. Animal context
“Dry” describes appearance. Users contrast harder-looking muscle and more visible veins with the bloated or water-heavy look they associate with LGD-4033. This vocabulary does not prove fat loss, retained muscle or lower health risk. Reddit r/SARMs Personal report
Forms and names matter. The discussion involves capsules, tablets and liquid products sold as research chemicals. “LGD” alone does not identify 3303, and seller-labelled milligrams do not verify the contents. Oral amounts cannot be transferred to an injectable preparation. Personal report Community Community

Benefits people seek and report

Strength and fuller-looking muscle. A nine-week user reported regained strength and about 15 lb of muscle while also taking methandienone, called Dbol. They explicitly credited muscle memory after returning to training; this is not 15 lb attributable to LGD-3303. Personal report
Hardness and vascularity. One testosterone-replacement-therapy (TRT) user preferred 3303 to 4033 for firmness, visible veins and abdominal definition. Neither amount was given, and TRT prevents a clean comparison. Reddit r/SARMs
Performance during a cut. A commenter described fuller muscles around week one and better strength around week two while dieting. That report gives no usable 3303 amount and cannot establish muscle retention or fat loss. Reddit r/SARMs

Doses people discuss

Circulated oral band: about 5–20 mg/day. This is a preserved vendor/forum template. Separate accounts report 10 mg/day with Dbol and 10 mg twice daily with enclomiphene, meaning 20 mg total per day. Neither stack establishes a useful or safe dose. Community Personal report Reddit r/SARMs
Another account: 8 mg morning and 8 mg night. That equals 16 mg/day; the contributor reported no gain after one week. Form and route were not specified in the comment. A larger daily total did not guarantee an early response. Reddit r/SARMs
The 5 mg/day report has an identity gap. A tablet user reported that total at week four, but a reply asks whether it was 4033 or 3303 without a visible answer. Their planned 7.5 mg in week five is not confirmed use. Personal report
Capsule log: 4 mg, then 8 mg/day. The bodybuilding log began with one 4 mg capsule and later reported two daily. Three capsules were still a plan; testosterone and numerous other agents were also used. Personal report

Half-life claims in the community

5–6 hours and 6–7 hours are circulated claims. The bodybuilding repost draws on rat research; the Reddit debate repeats 6–7 hours without human measurements. These claims concern decline in drug concentration, not how long strength gains or a workout feeling lasts. MuscleChemistry Reddit r/sarmssourcetalk
Divided use is disputed. Some contributors argue for two or three administrations daily; another favors once-daily use around training. Frequency preferences do not measure human half-life, and no validated human value emerges from these accounts. Reddit r/sarmssourcetalk Reddit r/SARMs

When people notice a change

First-day excitement versus no change at five days. One 10 mg/day logger described extra reps immediately and acknowledged it could be expectation. Another poster felt nothing after five days. These are separate users, not a dependable onset window. AnabolicMinds
About one to two weeks in one account. The dieting commenter noticed veins/fullness around week one and strength around week two. Another user noticed no gains after a week at 16 mg/day. Early irritability is a side effect, not proof of muscle growth. Reddit r/SARMs

How long effects are reported to last

No dependable one-dose benefit window. Workout-timing arguments do not establish how many hours a dose feels effective. One commenter reported irritability 1–2 hours after dosing while sleep stayed unchanged; that does not measure beneficial duration. Reddit r/SARMs Reddit r/SARMs
About two months after stopping in one stacked report. The Dbol user described lasting effects after the nine-week course. Regained muscle, training and the other drug make this a retention story, not evidence that LGD-3303 remains active for two months. Personal report

Courses and breaks people describe

Six to eight weeks is template language. The original chart records that range. A commenter actually described six weeks with enclomiphene; the Dbol account described about nine weeks. These distinct histories do not establish an ideal course. Community Reddit r/SARMs Personal report
Plans are different from completed courses. The ambiguous-LGD user was at week four and planned six more weeks. A bodybuilding logger proposed twelve weeks without a verified finish. No reliable off-period or hormonal-recovery timetable follows. Personal report AnabolicMinds Community

Good to know

Suppression can accompany favorable gym results. A six-week user reported total testosterone about 60% below baseline immediately afterward despite enclomiphene. They later reported returning to baseline after post-cycle treatment. This is one undocumented account, not proof that treatment guarantees recovery. Reddit r/SARMs
Hair, skin and mood are real tradeoffs in reports. Accounts include shedding, oily skin, acne and irritability. One user had shedding on 3303 but none on 4033. A dry-looking physique does not make these effects predictable or harmless. Reddit r/SARMs Reddit r/SARMs
Other drugs complicate both effects and risks. Dbol, TRT and enclomiphene appear in favorable stories. Interaction safety and long-term outcomes are unclear; lipid and hormone monitoring discussions do not establish that a stack is safe. Personal report Reddit r/SARMs Community
FDA warning: serious class risks. SARMs are unapproved drugs and cannot legally be marketed in the U.S. as supplements or drugs. FDA lists liver injury, heart attack/stroke, sexual dysfunction, infertility and miscarriage among associated harms. These are class warnings, not measured 3303-specific rates. Official context
Severe symptoms need medical care. Chest pain, sudden neurological changes, severe allergic symptoms or uncontrolled blood pressure/glucose need medical assessment. Feeling fine or finishing a forum calendar does not demonstrate recovery. Community

Supporting animal context

Rat half-life measurements stay separate. The 2009 paper's day-14 oral rat groups had mean elimination half-lives of 4.3–8.7 hours. Those are animal drug-concentration measurements, not a human interval, a felt-effect duration or an oral-to-injection conversion. Animal context

From community discussion

“Stronger” does not settle the tradeoff. A six-week commenter preferred performance to RAD-140 but reported acne, shedding and irritability. Another contributor reported no extra sides compared with RAD while using enclomiphene. A self-styled coach called 3303 less suppressive, which other replies disputed. Reddit r/SARMs Reddit r/SARMs
Tiredness can coexist with maintained strength. The show-preparation logger reported fatigue while retaining or improving lifts, amid a low-carb diet, testosterone and other agents. They could not isolate its cause. Personal report
Pumps can be uncomfortable. One contributor described pronounced pumps alongside fast visible mass changes and suppression. That is their experience, not a signal that discomfort proves an effective or safe product. Reddit r/SARMs
A positive report can still identify the wrong LGD. The week-four tablet user's better lifts, weight gain and definition are preserved, but the unresolved 4033-versus-3303 question changes what that story can tell us. A generic LGD review should not decide a 3303 comparison. Personal report